Bruker Corporation Declares Quarterly Dividend of $0.05 (NASDAQ:BRKR)

Bruker Corporation (NASDAQ:BRKR) announced a quarterly dividend on Tuesday, November 4th. Shareholders of record on Monday, December 8th will be given a dividend of 0.05 per share by the medical research company on Friday, January 2nd. This represents a c) dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Monday, December 8th.

Bruker has raised its dividend payment by an average of 0.0%per year over the last three years. Bruker has a dividend payout ratio of 7.3% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Bruker to earn $3.15 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 6.3%.

Bruker Stock Performance

BRKR traded down $0.23 during trading on Wednesday, reaching $40.15. 489,697 shares of the company’s stock were exchanged, compared to its average volume of 2,828,925. Bruker has a fifty-two week low of $28.53 and a fifty-two week high of $64.64. The company has a quick ratio of 0.70, a current ratio of 1.61 and a debt-to-equity ratio of 1.31. The business has a 50 day moving average price of $34.65 and a 200 day moving average price of $37.01. The company has a market capitalization of $6.09 billion, a P/E ratio of 77.27, a PEG ratio of 5.31 and a beta of 1.20.

Bruker (NASDAQ:BRKR) last announced its earnings results on Monday, November 3rd. The medical research company reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.12. The business had revenue of $860.50 million during the quarter, compared to analysts’ expectations of $847.40 million. Bruker had a net margin of 2.31% and a return on equity of 17.89%. The firm’s revenue for the quarter was down .5% on a year-over-year basis. During the same quarter last year, the company posted $0.60 EPS. Bruker has set its FY 2025 guidance at 1.850-1.90 EPS. As a group, analysts predict that Bruker will post 2.69 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Bruker news, Director Cynthia M. Friend sold 3,535 shares of the business’s stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $32.25, for a total transaction of $114,003.75. Following the completion of the sale, the director directly owned 18,016 shares of the company’s stock, valued at approximately $581,016. The trade was a 16.40% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 27.30% of the company’s stock.

Institutional Trading of Bruker

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. New York State Teachers Retirement System increased its stake in shares of Bruker by 0.8% in the 1st quarter. New York State Teachers Retirement System now owns 37,115 shares of the medical research company’s stock valued at $1,549,000 after acquiring an additional 300 shares during the last quarter. State of Michigan Retirement System increased its stake in Bruker by 1.1% during the 1st quarter. State of Michigan Retirement System now owns 26,493 shares of the medical research company’s stock worth $1,106,000 after purchasing an additional 300 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in Bruker by 1.0% during the 1st quarter. Louisiana State Employees Retirement System now owns 31,000 shares of the medical research company’s stock worth $1,294,000 after purchasing an additional 300 shares in the last quarter. Parallel Advisors LLC increased its stake in Bruker by 63.0% during the 2nd quarter. Parallel Advisors LLC now owns 898 shares of the medical research company’s stock worth $37,000 after purchasing an additional 347 shares in the last quarter. Finally, UMB Bank n.a. increased its stake in Bruker by 26.3% during the 2nd quarter. UMB Bank n.a. now owns 1,673 shares of the medical research company’s stock worth $69,000 after purchasing an additional 348 shares in the last quarter. 79.52% of the stock is owned by institutional investors.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.